Introduction

In a remarkable story of determination and passion, İmge Özügergin, a Concordia University alumna, has been recognized for her commitment to advancing public health through her innovative research. Recently awarded the prestigious Lady Mireille and Sir Dennis Gillings Global Public Health Fellowship, Özügergin joins a distinguished group of scholars with the potential to reshape the landscape of global health.

Academic Journey and Research Focus

Özügergin, who earned her MSc in 2019 and is set to complete her PhD in 2024, has always been driven by her fascination with the minutiae of life at the cellular level. Beginning her research in Concordia's Department of Biology, she has dedicated her studies to understanding cytokinesis—the final and crucial stage of cell division. This groundbreaking research has significant implications for the treatment of glioblastoma, a notoriously aggressive form of brain cancer that presents unique challenges for both patients and healthcare providers.

Personal Insights

"My journey is characterized by two pivotal roles in my life: being a postdoctoral researcher and a new mom," explains Özügergin. "I developed my love for science during my time at Concordia, where I focused on how cells divide and what can go wrong in that process, leading to diseases like cancer."

Simplifying Complex Concepts

For those unfamiliar with biological concepts, Özügergin simplifies her work: "Imagine starting as a single cell and ending up as around 37 trillion cells. Cytokinesis is the critical step where one cell splits into two. Disruptions in this process can lead to serious health issues, including miscarriages and cancer. Therefore, deciphering how this process works is crucial for understanding both normal biological functions and pathological conditions."

Significance of the Research

The urgency and significance of her research cannot be overstated. Özügergin aims to unravel the specific differences in cell division between healthy and glioblastoma-affected brain cells. By identifying malfunctions in the division process of these cancerous cells, she aspires to uncover new treatment targets, representing a fresh and promising approach in cancer therapy.

Collaborative Environment and Resources

"My excitement for conducting this research at the Institut Pasteur in Paris lies not only in the world-class equipment and facilities but also in the collaborative spirit among researchers," Özügergin emphasizes. "Access to some of the best microscopes will allow me to observe these extraordinary cells in action."

Impact of the Fellowship

The Lady Mireille Fellowship is not just a professional milestone for Özügergin; it also offers a unique opportunity for her personal life. "This fellowship is transformative for both my career and my family life," she says. "As a new mom, I can pursue my scientific ambitions while being present for my son’s growth—a balance that many in academia struggle to achieve. The fellowship liberates me from typical pressures and creates the space to explore my research passions."

Fellowship Overview

This two-year fellowship equips emerging scientists with the resources necessary to conduct unparalleled public health research at the globally recognized Institut Pasteur. In addition to research opportunities, fellows receive leadership and management training to amplify the impact of their work.

Eligibility for the Fellowship

The Lady Mireille and Sir Dennis Gillings Global Public Health Fellowship is available to recent PhD graduates from prestigious institutions, including the University of Cambridge, the University of North Carolina Gillings School of Global Public Health, and Concordia University.

Conclusion

Özügergin's journey is not only a testament to her dedication to science but also a powerful story of how balancing personal and professional aspirations can lead to groundbreaking advancements in global health. As she continues her research, the world watches closely, hopeful that her findings will pave the way for new breakthroughs in cancer treatment.